BU BÖLÜM HAKKINDA
This episode covers three research papers relevant to postmenopausal health: a Chinese study on whether a DNA-based cervical screening test performs differently after menopause, a clarification on a vitamin D drug used for bone thinning, and a cross-sectional study on whether dental imaging can flag low bone density before a formal bone scan is ever ordered.
Key Takeaways:
• A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
• Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
• A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
• The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
• All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References:
• PAX1 and JAM3 methylation for cervical screening in pre- vs. postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42830604/) - PubMed
• Eldecalcitol and calcium supplementation for postmenopausal osteoporosis: author reply (https://pubmed.ncbi.nlm.nih.gov/42830322/) - PubMed
• Dental CT scan gray values as a predictor of bone density in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42829977/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-10-05-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• A DNA methylation test used for cervical screening (PAX1/JAM3) appears to perform differently in postmenopausal women than in premenopausal women — which matters for how results should be read and acted on.
• Eldecalcitol, a stronger vitamin D drug used in some Asian countries for postmenopausal bone thinning, is not the same as the vitamin D supplement on your shelf — the distinction matters when reading research about it.
• A type of dental X-ray called a CBCT scan can estimate bone density in the jaw, and this study found meaningful overlap with formal bone density scores (DEXA T-scores) — a possible early-detection signal that most dental visits don't flag.
• The CBCT-bone density connection is cross-sectional and preliminary — it shows an association, not a proven screening tool. Researchers are not saying "skip the DEXA."
• All three studies are observational or retrospective, conducted primarily in Asian populations, and need replication before changing clinical practice in other groups.
Sources & References:
• PAX1 and JAM3 methylation for cervical screening in pre- vs. postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42830604/) - PubMed
• Eldecalcitol and calcium supplementation for postmenopausal osteoporosis: author reply (https://pubmed.ncbi.nlm.nih.gov/42830322/) - PubMed
• Dental CT scan gray values as a predictor of bone density in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42829977/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-10-05-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
ingilizce
Amerika Birleşik Devletleri
TRANSKRİPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
BU PODCAST'IN DİĞER BÖLÜMLERİ
Three new studies land this week with a shared theme the researchers didn't plan: the menopausal transition affects the brain and heart in ways that start earlier, run deeper, and differ more by sex than medicine has historically acknowledged. Nykki breaks down what a vulnerability window before de…
Three new studies look at what women are actually eating — and what it's doing to their bones, their vaginal microbiome, and their bladder. Nykki breaks down what the research says and what, if anything, is worth changing this weekend.
Key Takeaways:
• Many women at risk for bone thinning — includ…
This episode covers three new studies from October 2026: a year-long look at topical finasteride for postmenopausal hair loss, early-stage animal research on a cherry compound and bone density, and a large blood-donor dataset showing how iron and hemoglobin levels shift by age and season — with rea…
A new pilot study finds a possible link between a bone protein called osteocalcin and reduced brain connectivity in women with postmenopausal osteoporosis — raising questions about whether bone loss and brain fog share more biology than we thought. Then: a new study shows the ovaries don't just shu…
This episode covers three new studies from mid-to-late 2026: what women with PCOS say their experience actually looks like, how your sleep pattern over years — not just last night — connects to heart, kidney, and metabolic disease risk, and what postmenopausal women's diets have to do with their de…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan Hot Flasher'e aittir.
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
